- Record: found
- Abstract: found
- Article: not found
Association of Respiratory Allergy, Asthma and Expression of the SARS-CoV-2 Receptor, ACE2
brief-report
Daniel J. Jackson , MD
1
,
∗ ,
William W. Busse , MD
1 ,
Leonard B. Bacharier , MD
2 ,
Meyer Kattan , MD
3 ,
George T. O’Connor , MD
4 ,
Robert A. Wood , MD
5 ,
Cynthia M. Visness , PhD
6 ,
Stephen R. Durham , MD
7 ,
David Larson , PhD
8 ,
Stephane Esnault , PhD
2 ,
Carole Ober , PhD
9 ,
Peter J. Gergen , MD
10 ,
Patrice Becker , MD
10 ,
Alkis Togias , MD
10 ,
James E. Gern , MD
1 ,
Mathew C. Altman , MD
11
,
12
22 April 2020
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
Underlying respiratory allergy and experimental allergen exposure reduce the expression of the SARS-CoV-2 receptor, ACE2, which could lead to reduced COVID-19 susceptibility.